China Pharma Holdings, Inc. financial data

Symbol
CPHI on NYSE
Industry
Pharmaceutical Preparations
Location
2 Nd Floor, No. 17, Jinpan Road, Haikou, Hainan Province, China
State of incorporation
Delaware
Fiscal year end
December 31
Former names
TS ELECTRONICS INC (to 5/4/2006), SOFTSTONE INC (to 8/18/2003), SOFTSTONE INC /DE/ (to 1/27/2003), KILKENNY ACQUISITION CORP (to 3/30/2001)
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 64.4 % +8.11%
Quick Ratio 41.8 % +37.2%
Debt-to-equity 187 % -45.3%
Return On Equity -60.2 % +22.2%
Return On Assets -19 % +12.9%
Operating Margin -39.3 % +10.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 17.2M shares +50.1%
Common Stock, Shares, Outstanding 17.2M shares +103%
Entity Public Float 3.9M USD -63.2%
Common Stock, Value, Issued 17.2K USD -80.4%
Weighted Average Number of Shares Outstanding, Basic 16.1M shares +854%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 925K USD -15.8%
Cost of Revenue 1.94M USD +55.9%
Research and Development Expense 164K USD +592%
General and Administrative Expense 91.9K USD -18%
Operating Income (Loss) -1.39M USD -205%
Nonoperating Income (Expense) -46.6K USD +65.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -1.44M USD -143%
Net Income (Loss) Attributable to Parent -4.4M USD -41%
Earnings Per Share, Basic -0.09 USD/shares +74.3%
Earnings Per Share, Diluted -0.09 USD/shares +74.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.42M USD -29.9%
Accounts Receivable, after Allowance for Credit Loss, Current 255K USD
Inventory, Net 2.82M USD -28%
Assets, Current 3.97M USD -28.1%
Property, Plant and Equipment, Net 5.82M USD -30.3%
Operating Lease, Right-of-Use Asset 77.3K USD -49.3%
Intangible Assets, Net (Excluding Goodwill) 4.39M USD +161%
Assets 14.3M USD -9.19%
Accrued Liabilities, Current 209K USD +73.2%
Contract with Customer, Liability, Current 101K USD +64.8%
Liabilities, Current 4.71M USD -55.3%
Deferred Income Tax Liabilities, Net 738K USD +1.39%
Operating Lease, Liability, Noncurrent 39.9K USD
Liabilities 6.85M USD -39.6%
Common Stocks, Including Additional Paid in Capital 90K USD
Accumulated Other Comprehensive Income (Loss), Net of Tax 11.4M USD +1.16%
Retained Earnings (Accumulated Deficit) -41.7M USD -11.8%
Stockholders' Equity Attributable to Parent 7.41M USD +70.2%
Liabilities and Equity 14.3M USD -9.19%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.47M USD -66.9%
Net Cash Provided by (Used in) Financing Activities 518K USD
Net Cash Provided by (Used in) Investing Activities 56K USD
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 17.2M shares +103%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -863K USD +24.6%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 739K USD -18%
Interest Paid, Excluding Capitalized Interest, Operating Activities 22.9K USD -89.5%
Deferred Tax Assets, Valuation Allowance 21.5M USD -2.07%
Deferred Tax Assets, Gross 21.5M USD -2.07%
Operating Lease, Liability 78.6K USD -48.4%
Depreciation 637K USD -0.66%
Payments to Acquire Property, Plant, and Equipment 1.39K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -1.48M USD -32.9%
Lessee, Operating Lease, Liability, to be Paid 80.1K USD
Property, Plant and Equipment, Gross 37.3M USD +1.11%
Operating Lease, Liability, Current 78.6K USD +5.05%
Lessee, Operating Lease, Liability, to be Paid, Year Two 40.3K USD -1.67%
Lessee, Operating Lease, Liability, to be Paid, Year One 80.1K USD +1.39%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.52K USD -99%
Deferred Tax Assets, Operating Loss Carryforwards 2.08M USD +12.4%
Preferred Stock, Shares Authorized 5M shares 0%
Operating Lease, Payments 19.9K USD +6.42%
Additional Paid in Capital 37.7M USD +24.4%
Amortization of Intangible Assets 105K USD +90.2%
Depreciation, Depletion and Amortization 680K USD -4.72%
Interest Expense 334K USD -23.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%